Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Mathas, Stephan Dr. (1) (-) Schmitt, Clemens Prof. Dr. (6) 2002 (1) 2003 (3) 2004 (2) 2005 (2) 2006 (2) 2007 (4) 2010 (3) 2011 (3) 2012 (3) 2013 (2) 2014 (1) 2016 (8) 2019 (7) 2020 (7) 2021 (11) 2022 (10) (-) 2023 (6) 2024 (4) Biology of Malignant Lymphomas (1) (-) Cancer Genetics and Cellular Stress Responses (6) 6 Results: Active Filter: Schmitt, Clemens Prof. Dr.Cancer Genetics and Cellular Stress Responses2023 Sort: Result score Newest to oldest Oldest to newest June 15, 2023 / J Clin Invest Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors A. Bonifacius B. Lamottke S. Tischer-Zimmermann R. Schultze-Florey L. Goudeva H.G. Heuft L. Arseniev R. Beier G. Beutel G. Cario B. Fröhlich J. Greil L. Hansmann J. Hasenkamp M. Höfs P. Hundsdoerfer E. Jost K. Kafa O. Kriege N. Kröger S. Mathas R. Meisel M. Nathrath M. Putkonen S. Ravens H.C. Reinhardt E. Sala M.G Sauer C. Schmitt R. Schroers N.K. Steckel R.U. Trappe M. Verbeek D. Wolff R. Blasczyk B. Eiz-Vesper B. Maecker-Kolhoff May 06, 2023 / Cell Death Discov N6-methyladenine-mediated aberrant activation of the lncRNA SOX2OT-GLI1 loop promotes non-small-cell lung cancer stemness Hongliang Dong Lili Zeng Weiwei Chen Qian Zhang Fei Wang Yan Wu Bingjie Cui Jingjing Qi Xin Zhang Cuilan Liu Jiong Deng Y. Yu C.A. Schmitt Jing Du November, 2023 / Am J Hematol Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine - a prospective cohort study by the AGMT L. Pleyer M. Vaisband M. Drost M. Pfeilstöcker R. Stauder S. Heibl H. Sill M. Girschikofsky M. Stampfl-Mattersberger A. Pichler B. Hartmann A. Petzer M. Schreder C.A. Schmitt S. Vallet T. Melchardt A. Zebisch P. Pichler N. Zaborsky S. Machherndl-Spandl D. Wolf F. Keil J. Hasenauer J. Larcher-Senn R. Greil May, 2023 / Cell Mol Neurobiol Protein biomarkers in blood reflect the interrelationships between stroke outcome, inflammation, coagulation, adhesion, senescence and cancer G. Fuellen U. Walter L. Henze J. Böhmert D. Palmer S. Lee C.A. Schmitt H. Rudolf A. Kowald April, 2023 / Nat Rev Immunol COVID-19 and cellular senescence C.A. Schmitt T. Tchkonia L.J. Niedernhofer P.D. Robbins J.L. Kirkland S. Lee March, 2023 / Blood Cells Mol Dis Daratumumab as a novel treatment option in refractory ITP I. Vernava C.A. Schmitt
June 15, 2023 / J Clin Invest Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors A. Bonifacius B. Lamottke S. Tischer-Zimmermann R. Schultze-Florey L. Goudeva H.G. Heuft L. Arseniev R. Beier G. Beutel G. Cario B. Fröhlich J. Greil L. Hansmann J. Hasenkamp M. Höfs P. Hundsdoerfer E. Jost K. Kafa O. Kriege N. Kröger S. Mathas R. Meisel M. Nathrath M. Putkonen S. Ravens H.C. Reinhardt E. Sala M.G Sauer C. Schmitt R. Schroers N.K. Steckel R.U. Trappe M. Verbeek D. Wolff R. Blasczyk B. Eiz-Vesper B. Maecker-Kolhoff
May 06, 2023 / Cell Death Discov N6-methyladenine-mediated aberrant activation of the lncRNA SOX2OT-GLI1 loop promotes non-small-cell lung cancer stemness Hongliang Dong Lili Zeng Weiwei Chen Qian Zhang Fei Wang Yan Wu Bingjie Cui Jingjing Qi Xin Zhang Cuilan Liu Jiong Deng Y. Yu C.A. Schmitt Jing Du
November, 2023 / Am J Hematol Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine - a prospective cohort study by the AGMT L. Pleyer M. Vaisband M. Drost M. Pfeilstöcker R. Stauder S. Heibl H. Sill M. Girschikofsky M. Stampfl-Mattersberger A. Pichler B. Hartmann A. Petzer M. Schreder C.A. Schmitt S. Vallet T. Melchardt A. Zebisch P. Pichler N. Zaborsky S. Machherndl-Spandl D. Wolf F. Keil J. Hasenauer J. Larcher-Senn R. Greil
May, 2023 / Cell Mol Neurobiol Protein biomarkers in blood reflect the interrelationships between stroke outcome, inflammation, coagulation, adhesion, senescence and cancer G. Fuellen U. Walter L. Henze J. Böhmert D. Palmer S. Lee C.A. Schmitt H. Rudolf A. Kowald
April, 2023 / Nat Rev Immunol COVID-19 and cellular senescence C.A. Schmitt T. Tchkonia L.J. Niedernhofer P.D. Robbins J.L. Kirkland S. Lee
March, 2023 / Blood Cells Mol Dis Daratumumab as a novel treatment option in refractory ITP I. Vernava C.A. Schmitt